New York lab CEO allegedly billed insurers for $500M in fraudulent COVID test claims
By 
Adrianne Appel2025-08-04T18:13:00
The chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests, the U.S. Department of Justice (DOJ) said.
Fast Lab CEO Cemhan “Jimmy” Biricik and medical director, Martin Perlin, M.D., created the business and its website in 2021, during the height of the pandemic, and advertised “free” COVID-19 tests.
Fast Lab, based in New York, collected individuals’ insurance information and used it to fraudulently bill private insurers and federal health programs, including Medicare, Medicaid, and TRICARE, for COVID-19 testing that never took place, the DOJ alleged.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleHorizon Blue Cross Blue Shield pays $100M to settle state false claims allegations
Horizon Blue Cross Blue Shield of New Jersey has agreed to pay $100 million to settle allegations that its 2020 contract with the state was fraudulent, according the state’s Attorney General.
-
ArticleDOJ is ramping up, not ramping down, health care fraud enforcement
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.
-
Basic PageNestlé CEO dismissed after code of conduct breach
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
More from Regulatory Enforcement
-
ArticleTariff evasion enforcement: The new FCPA
Companies that import goods into the United States will face heightened enforcement scrutiny for attempted acts of customs fraud, including tariff evasion, under the Trump administration. Thus, chief compliance officers and in-house counsel face a new kind of pressure to ensure they are mitigating risk in this area.
-
ArticleFormer COO of plastics importer faces up to five years for customs falsifications
The chief operating officer of a plastic resin importer has pleaded guilty to intentionally falsifying documents to avoid paying tariffs on goods from China, the Department of Justice (DOJ) announced.
-
ArticleCybercrime against banks and account holders takes hit from FBI
Federal investigators have announced progress in dismantling an online criminal operation that steals bank account information by mimicking legitimate bank websites.